Welcome to LookChem.com Sign In|Join Free

CAS

  • or

88546-12-7

Post Buying Request

88546-12-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88546-12-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 88546-12-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,5,4 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 88546-12:
(7*8)+(6*8)+(5*5)+(4*4)+(3*6)+(2*1)+(1*2)=167
167 % 10 = 7
So 88546-12-7 is a valid CAS Registry Number.

88546-12-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl (R)-2-acetamido-3-(4-nitrophenyl)propanoate

1.2 Other means of identification

Product number -
Other names (R)-N-(-)-acetyl-4-nitrophenylalanine methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88546-12-7 SDS

88546-12-7Relevant articles and documents

Mechanistically Guided One Pot Synthesis of Phosphine-Phosphite and Its Implication in Asymmetric Hydrogenation

Sen, Anirban,Kumar, Rohit,Pandey, Swechchha,Vipin Raj,Kumar, Pawan,Vanka, Kumar,Chikkali, Samir H.

, (2022/01/11)

Although hybrid bidentate ligands are known to yield highly enantioselective products in asymmetric hydrogenation (AH), synthesis of these ligands is an arduous process. Herein, a one pot, atom-economic synthesis of a hybrid phosphine-phosphite (L1) is reported. After understanding the reactivity difference between an O-nucleophile versus C-nucleophile, one pot synthesis of Senphos (L1) was achieved (72 %). When L1 was treated with [Rh], 31P NMR revealed bidentate coordination to Rh. Senphos, in the presence of rhodium, catalyzes the AH of Methyl-2-acetamido-3-phenylacrylate and discloses an unprecedented turn over frequency of 2289, along with excellent enantio-selectivity (92 %). The generality is demonstrated by hydrogenating an array of alkenes. The AH operates under mild conditions of 1–2 bar H2 pressure, at room temperature. The practical relevance of L1 is demonstrated by scaling-up the reaction to 1 g and by synthesizing DOPA, a drug widely employed for the treatment of Parkinson's disease. Computational insights indicate that the R isomer is preferred by 3.8 kcal/mol over the S isomer.

Melphalan intermediate and preparation method thereof

-

Paragraph 0043; 0050; 0056-0057; 0107; 0114; 0120-0121; 0171, (2019/08/02)

The invention discloses a Melphalan intermediate and a preparation method thereof. The Melphalan intermediate is prepared by acidifying a compound p-nitrobenzaldehyde under the action of methanol, a hydrochloric acid solvent, etc. The preparation method has a route with mild reaction conditions, is higher than an existing preparation method in yield, is economical and effective, and is suitable for large-scale industrial production. The synthesis route is as shown in the description.

Model containing pyridine base crown ether chiral bis-phosphorus ligand and its in asymmetric catalytic application of the catalyst in the reaction (by machine translation)

-

Paragraph 0122; 0123; 0124, (2016/10/10)

This invention relates to model containing pyridine base crown ether chiral bis-phosphorus ligand and its application of symmetrical catalytic reaction. Chiral bis-phosphorus ligand and intermediates containing pyridine base crown ether single phosphorus ligand the structural formula of (I) are respectively shown as the following formula, formula (I '). These chiral bis-phosphorus ligand of the transition metal complexes can be used as catalyst for asymmetric reactions, containing pyridine base crown ether of the invention the chiral bis-phosphorus ligand it is a kind of novel chiral ligand capable of regulating, by using different alkali metal ion, alkaline earth metal ion, rare-earth metal ion, ammonium salt or organic amine salt such as a crown ether, on the object with the ligand complex, the catalyst can be realized the space structure and electronic nature of the regulation and control. This kind of the alkali metal ion complexation assembled containing pyridine base crown ether chiral double-phosphorus ligand transition metal (Rh and Ir) complexes in catalytic hydrogenation reaction demonstrate excellent catalytic activity and good stereoselectivity. (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 88546-12-7